Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 1 - 10 of 121
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Shandong Provincial Institute, China, Technology for Family Planning, China
Project Stage: Pre-clinical
Alternative Name: Inhibitors of Testicular Retinoic Acid Biosynthesis
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: University of Washington, University of Minnesota
Project Stage: Pre-clinical
Alternative Name: ARC; triple hormone contraceptive; Triple OC
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Oral
Developer: ANI Pharmaceuticals, Pantarhei Bioscience
Project Stage: Phase II
Alternative Name: Suspensories
Active Status: No
User: Male
Mode: No
Delivery Type: Testicular
Developer: Centre Hospitalier Universitaire de Toulouse, France
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: FHI 360, Yale University
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Shanghai Institute of Planned Parenthood Research (SIPPR)
Project Stage: Pre-clinical
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: University of Washington
Project Stage: Pre-clinical
Alternative Name: BDADs
Active Status: No
User: Female, Male
Mode: No
Delivery Type: Oral
Developer: Focused Scientific, University of Washington
Project Stage: Pre-clinical
Active Status: No
User: Female
Mode: No
Delivery Type: Vaginal Gel
Developer: ReProtect Inc.
Project Stage: Phase III

Pages

CSV